Groundbreaking stem cell therapy trial for Alzheimer’s disease underway at UTHealth Houston

A stem cell therapy trial aimed at reducing neuroinflammation in patients with presymptomatic Alzheimer’s disease is underway at UTHealth Houston.

US trade commission explores impact of patent rules on COVID diagnostics

Listen to the article 3 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: The U.S. International Trade Commission

October 23, 2023

RG-6315 by Genentech USA for Inflammation: Likelihood of Approval

Share this article GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug

April 20, 2024

Talazoparib-Enzalutamide Improves Survival in Metastatic CRPC

SAN FRANCISCO — Adding talazoparib (Talzenna) to enzalutamide (Xtandi) as initial treatment for metastatic castration-resistant prostate cancer (CRPC) prolonged survival, new analyses from the TALAPRO-2

February 14, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.